Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABD.L Regulatory News (ABD)

  • There is currently no data for ABD

Research from QuotedData

7 Jun 2022 15:31

RNS Number : 0437O
abrdn New Dawn Invest Trust plc
07 June 2022
 

abrdn New Dawn - Research from QuotedData

 

7th June 2022

 

Over the trough?

 

It has been another tough six months for abrdn New Dawn (ABD) as the Asia Pacific region has had to face new challenges from the Russo-Ukrainian conflict to China's deadliest COVID-19 wave yet (the economic impacts of which have been made worse by Xi Jinping's zero-COVID policy). This has only exacerbated headwinds already in place such as rising inflation. Manager James Thom believes the worst is behind us, but uncertainty and volatility remain. The trust itself has underperformed in the short-term but still boasts strong long-term numbers and, if a new dawn is indeed rising over the region, with India finally enjoying its reformation and the vaccine rollout (mostly) underway, now could be an attractive entry point. The trust is also trading on an 12.4% discount.

 

Full research:

https://quoteddata.com/research/abrdn-new-dawn-over-the-trough-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on abrdn New Dawn Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBUSRUKUNRAR
Date   Source Headline
8th Aug 202311:54 amRNSNet Asset Value(s)
7th Aug 20232:53 pmRNSGearing Disclosures
7th Aug 202312:53 pmRNSNet Asset Value(s)
4th Aug 20234:25 pmRNSMonth End Net Asset Value(s)
4th Aug 202312:01 pmRNSNet Asset Value(s)
3rd Aug 202312:47 pmRNSNet Asset Value(s)
2nd Aug 20233:12 pmRNSQuarterly disclosure
2nd Aug 202312:41 pmRNSNet Asset Value(s)
1st Aug 202310:21 amRNSTotal Voting Rights
1st Aug 202310:10 amRNSBlock listing Interim Review
31st Jul 20234:44 pmRNSGearing disclosure
31st Jul 202312:39 pmRNSNet Asset Value(s)
31st Jul 202311:43 amRNSSecond Interim Dividend
28th Jul 202312:23 pmRNSNet Asset Value(s)
27th Jul 202311:51 amRNSNet Asset Value(s)
26th Jul 202311:31 amRNSNet Asset Value(s)
25th Jul 202311:44 amRNSNet Asset Value(s)
24th Jul 20232:51 pmRNSGearing disclosure
24th Jul 202311:31 amRNSNet Asset Value(s)
21st Jul 202311:42 amRNSNet Asset Value(s)
21st Jul 20237:00 amRNSProposed Combination with Asia Dragon Trust plc
20th Jul 202312:37 pmRNSNet Asset Value(s)
19th Jul 202312:13 pmRNSNet Asset Value(s)
18th Jul 202311:45 amRNSNet Asset Value(s)
17th Jul 20231:14 pmRNSGearing disclosure
17th Jul 202312:02 pmRNSNet Asset Value(s)
14th Jul 20234:59 pmRNSPortfolio Disclosures
14th Jul 20234:25 pmRNSHolding(s) in Company
14th Jul 202312:21 pmRNSNet Asset Value(s)
14th Jul 20239:51 amRNSNet Asset Value(s)
12th Jul 202312:25 pmRNSNet Asset Value(s)
11th Jul 20233:52 pmRNSHolding(s) in Company
11th Jul 202312:48 pmRNSNet Asset Value(s)
10th Jul 20234:54 pmRNSGearing disclosure
10th Jul 202312:48 pmRNSNet Asset Value(s)
7th Jul 202312:59 pmRNSNet Asset Value(s)
6th Jul 20233:50 pmRNSMonth End Net Asset Value(s)
6th Jul 202312:34 pmRNSNet Asset Value(s)
5th Jul 202312:38 pmRNSNet Asset Value(s)
4th Jul 20235:19 pmRNSTransaction in Own Shares
4th Jul 20234:52 pmRNSGearing disclosure
4th Jul 202312:28 pmRNSNet Asset Value(s)
3rd Jul 20234:23 pmRNSHolding(s) in Company
3rd Jul 202310:49 amRNSTotal Voting Rights
30th Jun 20231:24 pmRNSNet Asset Value(s)
29th Jun 20235:15 pmRNSTransaction in Own Shares
29th Jun 202312:48 pmRNSNet Asset Value(s)
28th Jun 20235:09 pmRNSTransaction in Own Shares
28th Jun 202311:31 amRNSNet Asset Value(s)
27th Jun 20235:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.